Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Short term Debt (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Short term Debt for 17 consecutive years, with $2.3 billion as the latest value for Q4 2025.

  • Quarterly Short term Debt rose 10.51% to $2.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 billion through Dec 2025, up 10.51% year-over-year, with the annual reading at $2.3 billion for FY2025, 10.51% up from the prior year.
  • Short term Debt for Q4 2025 was $2.3 billion at Bristol Myers Squibb, down from $4.5 billion in the prior quarter.
  • The five-year high for Short term Debt was $7.5 billion in Q1 2022, with the low at $1.1 billion in Q3 2024.
  • Average Short term Debt over 5 years is $3.8 billion, with a median of $3.5 billion recorded in 2024.
  • The sharpest move saw Short term Debt soared 323.3% in 2022, then crashed 80.28% in 2024.
  • Over 5 years, Short term Debt stood at $4.9 billion in 2021, then fell by 13.82% to $4.3 billion in 2022, then dropped by 26.85% to $3.1 billion in 2023, then crashed by 34.4% to $2.0 billion in 2024, then rose by 10.51% to $2.3 billion in 2025.
  • According to Business Quant data, Short term Debt over the past three periods came in at $2.3 billion, $4.5 billion, and $4.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.